Novo se alía con Anthropic para acelerar el desarrollo de medicamentos antiobesidad con la IA de Claude

🇪🇸 El País (ES) —

AI Summary

Spanish pharmaceutical company Novo has partnered with AI firm Anthropic to accelerate the development of anti-obesity drugs using Claude AI technology. Novo aims to become the world's most AI-driven healthcare company and to discover new scientific opportunities.

La farmacéutica aspira a “convertirse en la compañía sanitaria del mundo más impulsada por la IA” y descubrir “oportunidades científicas completamente nuevas”

Deals Health AI & Tech Novo Anthropic Claude AI anti-obesity drugs pharmaceuticals AI in healthcare

Read original source →